5/5-5/6付の英国MHRAからのCOVID-19関連通知（更新を含む）です。
ただ、GMP Platform読者に関係しそうなものだけを取り上げていますことをご容赦ください。
関係者および興味のある方は、下記URLsのウェブサイトをご参照ください。
l5/6付News Release「New reagent available to support global diagnostic testing of coronavirus (COVID-19)」
https://www.gov.uk/government/news/new-reagent-available-to-support-global-diagnostic-testing-of-coronavirus-covid-19
l5/6付Updated「MHRA guidance on coronavirus (COVID-19)」
https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-19
l5/5付Updated「The Yellow Card scheme: guidance for healthcare professionals, patients and the public」～「Reporting during the Coronavirus (COVID-19) outbreak」の追加です。
https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals
［上記関連ニュース記事］
l5/6付FDAnews Drug Daily Bulleti「MHRA Launches Website for COVID-19 Related Adverse Events」
https://www.fdanews.com/articles/196976-mhra-launches-website-for-covid-19-related-adverse-events
l5/5付Updated「Specification for Rapidly Manufactured CPAP System to be used during the coronavirus (COVID-19) outbreak」
https://www.gov.uk/government/publications/specification-for-rapidly-manufactured-cpap-system-to-be-used-during-the-coronavirus-covid-19-outbreak
ただ、GMP Platform読者に関係しそうなものだけを取り上げています
関係者および興味のある方は、下記URLsのウェブサイトをご参
l5/6付News Release「New reagent available to support global diagnostic testing of coronavirus (COVID-19)」
https://www.gov.uk/government/
l5/6付Updated「MHRA guidance on coronavirus (COVID-19)」
https://www.gov.uk/government/
l5/5付Updated「The Yellow Card scheme: guidance for healthcare professionals, patients and the public」～「Reporting during the Coronavirus (COVID-19) outbreak」の追加です。
https://www.gov.uk/guidance/
［上記関連ニュース記事］
l5/6付FDAnews Drug Daily Bulleti「MHRA Launches Website for COVID-19 Related Adverse Events」
https://www.fdanews.com/
l5/5付Updated「Specification for Rapidly Manufactured CPAP System to be used during the coronavirus (COVID-19) outbreak」
https://www.gov.uk/government/
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント